Jingwen Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jingwen Zhang has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
Alfred A. Rabow
1 shared publication- Alice E. Smith
Department of Industrial and Systems Engineering, Auburn University, Auburn, Alabama 36849
1 shared publication Austin Dulak
1 shared publicationBai Hongyuan
Department of Cardiology, Second Affiliated Hospital, School of Medicine, Xian Jiaotong University, Xi’an, China
1 shared publicationBilaal Ahmad
King's College Hospital NHS Foundation Trust
1 shared publicationChanggen Xu
Zhenjiang Blood Center, zhenjiang,jiangsu, Zhenjiang, 212013, CHINA
1 shared publication
Latest Publications
- Open Access
- 10 February 2025
- Published by Taylor & Francis in Accounting and Business Research
- Vol. 56 (2) , 216-253
CEO charity involvement and corporate performance in promoting stakeholders’ interest
- 10 February 2025
- Published by Taylor & Francis in Accounting and Business Research
- Vol. 56 (2) , 216-253
Open AccessCEO charity involvement and corporate performance in promoting stakeholders’ interest
- Open Access
- 24 January 2024
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (2) , 025016
A ROS-responsive loaded desferoxamine (DFO) hydrogel system for traumatic brain injury therapy
Traumatic brain injury (TBI) produces excess iron, and increased iron accumulation in the brain leads to lipid peroxidation and reactive oxygen species (ROSs), which can exacerbate secondary damage and lead to disability and death. Therefore, inhibition of iron overload and oxidative stress has a significant role in the treatment of TBI. Functionalized hydrogels with iron overload inhibiting ability and of oxidative stress inhibiting ability will greatly contribute to the repair of TBI. Herein, an injectable, post-traumatic microenvironment-responsive, ROS-responsive hydrogel encapsulated with deferrioxamine mesylate (DFO) was developed. The hydrogel is rapidly formed via dynamic covalent bonding between phenylboronic acid grafted hyaluronic acid (HA-PBA) and polyvinyl alcohol (PVA), and phenylboronate bonds are used to respond to and reduce ROS levels in damaged brain tissue to promote neuronal recovery. The release of DFO from HA-PBA/PVA hydrogels in response to ROS further promotes neuronal regeneration and recovery by relieving iron overload and thus eradicating ROS. In the Feeney model of Sprague Dawley rats, HA-PBA/PVA/DFO hydrogel treatment significantly improved the behavior of TBI rats and reduced the area of brain contusion in rats. In addition, HA-PBA/PVA/DFO hydrogel significantly reduced iron overload to reduce ROS and could effectively promote post-traumatic neuronal recovery. Its effects were also explored, and notably, HA-PBA/PVA/DFO hydrogel can reduce iron overload as well as ROS, thus protecting neurons from death. Thus, this injectable, biocompatible and ROS-responsive drug-loaded hydrogel has great potential for the treatment of TBI. This work suggests a novel method for the treatment of secondary brain injury by inhibiting iron overload and the oxidative stress response after TBI.
- 24 January 2024
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (2) , 025016
Open AccessA ROS-responsive loaded desferoxamine (DFO) hydrogel system for traumatic brain injury therapy
Traumatic brain injury (TBI) produces excess iron, and increased iron accumulation in the brain leads to lipid peroxidation and reactive oxygen species (ROSs), which can exacerbate secondary damage and lead to disability and death. Therefore, inhibition of iron overload and oxidative stress has a significant role in the treatment of TBI. Functionalized hydrogels with iron overload inhibiting ability and of oxidative stress inhibiting ability will greatly contribute to the repair of TBI. Herein, an injectable, post-traumatic microenvironment-responsive, ROS-responsive hydrogel encapsulated with deferrioxamine mesylate (DFO) was developed. The hydrogel is rapidly formed via dynamic covalent bonding between phenylboronic acid grafted hyaluronic acid (HA-PBA) and polyvinyl alcohol (PVA), and phenylboronate bonds are used to respond to and reduce ROS levels in damaged brain tissue to promote neuronal recovery. The release of DFO from HA-PBA/PVA hydrogels in response to ROS further promotes neuronal regeneration and recovery by relieving iron overload and thus eradicating ROS. In the Feeney model of Sprague Dawley rats, HA-PBA/PVA/DFO hydrogel treatment significantly improved the behavior of TBI rats and reduced the area of brain contusion in rats. In addition, HA-PBA/PVA/DFO hydrogel significantly reduced iron overload to reduce ROS and could effectively promote post-traumatic neuronal recovery. Its effects were also explored, and notably, HA-PBA/PVA/DFO hydrogel can reduce iron overload as well as ROS, thus protecting neurons from death. Thus, this injectable, biocompatible and ROS-responsive drug-loaded hydrogel has great potential for the treatment of TBI. This work suggests a novel method for the treatment of secondary brain injury by inhibiting iron overload and the oxidative stress response after TBI.
- Open Access
Uncovering the System Vulnerability and Criticality of Human Brain under Dynamical Neuropathological Events in Alzheimer's Disease
Background: Despite the striking efforts in investigating neurobiological factors behind the acquisition of amyloid-\b{eta} (A), protein tau (T), and neurodegeneration ([N]) biomarkers, the mechanistic pathways of how AT[N] biomarkers spreading throughout the brain remain elusive. Objectives: To disentangle the massive heterogeneities in AD progressions and identify vulnerable/critical brain regions to AD pathology. Methods: In this work, we characterized the interaction of AT[N] biomarkers and their propagation across brain networks using a novel bistable reaction-diffusion model, which allows us to establish a new systems biology underpinning of Alzheimer's disease (AD) progression. We applied our model to large-scale longitudinal neuroimages from the ADNI database and studied the systematic vulnerability and criticality of brains. Results: Our model yields long term prediction that is statistically significant linear correlated with temporal imaging data, produces clinically consistent risk prediction, and captures the Braak-like spreading pattern of AT[N] biomarkers in AD development. Conclusion: Our major findings include (i) tau is a stronger indicator of regional risk compared to amyloid, (ii) temporal lobe exhibits higher vulnerability to AD-related pathologies, (iii) proposed critical brain regions outperform hub nodes in transmitting disease factors across the brain, and (iv) comparing the spread of neuropathological burdens caused by amyloid-\b{eta} and tau diffusions, disruption of metabolic balance is the most determinant factor contributing to the initiation and progression of Alzheimer's disease.
Open AccessUncovering the System Vulnerability and Criticality of Human Brain under Dynamical Neuropathological Events in Alzheimer's Disease
Background: Despite the striking efforts in investigating neurobiological factors behind the acquisition of amyloid-\b{eta} (A), protein tau (T), and neurodegeneration ([N]) biomarkers, the mechanistic pathways of how AT[N] biomarkers spreading throughout the brain remain elusive. Objectives: To disentangle the massive heterogeneities in AD progressions and identify vulnerable/critical brain regions to AD pathology. Methods: In this work, we characterized the interaction of AT[N] biomarkers and their propagation across brain networks using a novel bistable reaction-diffusion model, which allows us to establish a new systems biology underpinning of Alzheimer's disease (AD) progression. We applied our model to large-scale longitudinal neuroimages from the ADNI database and studied the systematic vulnerability and criticality of brains. Results: Our model yields long term prediction that is statistically significant linear correlated with temporal imaging data, produces clinically consistent risk prediction, and captures the Braak-like spreading pattern of AT[N] biomarkers in AD development. Conclusion: Our major findings include (i) tau is a stronger indicator of regional risk compared to amyloid, (ii) temporal lobe exhibits higher vulnerability to AD-related pathologies, (iii) proposed critical brain regions outperform hub nodes in transmitting disease factors across the brain, and (iv) comparing the spread of neuropathological burdens caused by amyloid-\b{eta} and tau diffusions, disruption of metabolic balance is the most determinant factor contributing to the initiation and progression of Alzheimer's disease.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies
Differentially expressed genes with AZD5153 treatment
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies
Differentially expressed genes with AZD5153 treatment
- 4 November 2022
- Published by Elsevier in Clinical Radiology
- Vol. 77, e36-e37
Implementation of an electronic porter requesting tool for inpatient radiographs at the Princess Royal University Hospital
- 4 November 2022
- Published by Elsevier in Clinical Radiology
- Vol. 77, e36-e37
Implementation of an electronic porter requesting tool for inpatient radiographs at the Princess Royal University Hospital
- Open Access
- 12 February 2022
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
The comparison of therapeutic effects of different traditional Chinese Medicine Exercise Therapies on essential hypertension: a systematic review and network meta-analysis of randomized controlled trials
INPLASY202220036 The comparison of therapeutic effects of different traditional Chinese Medicine Exercise Therapies on essential hypertension: a systematic review and network meta-analysis of rando…
- 12 February 2022
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Open AccessThe comparison of therapeutic effects of different traditional Chinese Medicine Exercise Therapies on essential hypertension: a systematic review and network meta-analysis of randomized controlled trials
INPLASY202220036 The comparison of therapeutic effects of different traditional Chinese Medicine Exercise Therapies on essential hypertension: a systematic review and network meta-analysis of rando…
- 17 January 2022
- Published by Elsevier in Materials Chemistry and Physics
- Vol. 279, 125761
Effect of loading rate of nano-silver on degradation of methyl orange by AgNPs@SBPN composite catalyst
- 17 January 2022
- Published by Elsevier in Materials Chemistry and Physics
- Vol. 279, 125761
Effect of loading rate of nano-silver on degradation of methyl orange by AgNPs@SBPN composite catalyst
- Open Access
- 1 January 2021
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 11 (10) , 1615623-1611623
Functional characterization of a KCNAB3 genetic epilepsy with febrile seizures plus adult mouse model
Original Article Functional characterization of a KCNAB3 genetic epilepsy with febrile seizures plus adult mouse model Jian Ding, Chun Wang, Guo-Qiang Huang, Jing-Wen Zhang, Qiong-Xiang Zhai, Zhi-Hong Chen, Yu-Xin Zhang, Yu-Xiong Guo
- 1 January 2021
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 11 (10) , 1615623-1611623
Open AccessFunctional characterization of a KCNAB3 genetic epilepsy with febrile seizures plus adult mouse model
Original Article Functional characterization of a KCNAB3 genetic epilepsy with febrile seizures plus adult mouse model Jian Ding, Chun Wang, Guo-Qiang Huang, Jing-Wen Zhang, Qiong-Xiang Zhai, Zhi-Hong Chen, Yu-Xin Zhang, Yu-Xiong Guo
- Open Access
- 1 January 2021
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 11 (3) , 423-424
Does early supplementation of vitamin A show good efficacy on the prevention of bronchopulmonary dysplasia?
Does early supplementation of vitamin A show good efficacy on the prevention of bronchopulmonary dysplasia? Jiangfeng Wu, Peiwen Wang, Weiqiang Bao, Jingwen Zhang, Yun Jin
- 1 January 2021
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 11 (3) , 423-424
Open AccessDoes early supplementation of vitamin A show good efficacy on the prevention of bronchopulmonary dysplasia?
Does early supplementation of vitamin A show good efficacy on the prevention of bronchopulmonary dysplasia? Jiangfeng Wu, Peiwen Wang, Weiqiang Bao, Jingwen Zhang, Yun Jin
- 1 August 2020
- Published by Elsevier in Chemosphere
- Vol. 253, 126762
Melatonin attenuates 17β-trenbolone induced insomnia-like phenotype and movement deficiency in zebrafish
- 1 August 2020
- Published by Elsevier in Chemosphere
- Vol. 253, 126762
Melatonin attenuates 17β-trenbolone induced insomnia-like phenotype and movement deficiency in zebrafish